Zosano Pharma Corporation (Nasdaq: ZSAN) announced completion of enrollment in its registration-enabling, pivotal efficacy trial (the Zotrip trial) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE